- Home
- DNLI vs WING Comparison
DNLI vs WING Comparison
Compare DNLI & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | WING |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DNLI | WING |
|---|---|---|
| Price | $24.85 | $155.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 27 |
| Target Price | $34.33 | ★ $295.92 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | N/A | ★ 67.84 |
| EPS | N/A | ★ 1.08 |
| Revenue | N/A | ★ $696,853,000.00 |
| Revenue This Year | N/A | $17.20 |
| Revenue Next Year | $408.85 | $15.86 |
| P/E Ratio | ★ N/A | $139.27 |
| Revenue Growth | N/A | ★ 11.35 |
| 52 Week Low | $12.58 | $116.35 |
| 52 Week High | $25.31 | $381.45 |
Technical Indicators
Market Signals| Indicator | DNLI | WING |
|---|---|---|
| Relative Strength Index (RSI) | 74.12 | 51.92 |
| Support Level | $18.27 | $139.01 |
| Resistance Level | N/A | $162.38 |
| Average True Range (ATR) | 1.24 | 9.12 |
| MACD | 0.44 | 0.88 |
| Stochastic Oscillator | 88.15 | 49.22 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About WING Wingstop Inc.
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.